Molecular diagnostics company, Rosetta Genomics Ltd., announced that its novel assay for differential diagnosis of thyroid neoplasia is on track for launch by the end of the third quarter of 2015. The company provided an update on the development of its microRNA-based assay for the differential diagnosis of thyroid neoplasia, …